ROKIT HEALTHCARE Subsidiary ROKIT AMERICA Plans Nasdaq Listing to Fund Global Expansion of Long-Term Regeneration Platform
ROKIT HEALTHCARE's wholly-owned subsidiary ROKIT AMERICA has decided to list on the Nasdaq Global Market in the US.
The purpose of the listing is to raise funds for R&D, regulatory strategy, commercialization, and marketing of the long-term regeneration platform ORP and reverse aging business, as well as general corporate purposes such as working capital.
The number of shares to be issued and the listing date are not yet confirmed and will be disclosed upon determination. The subsidiary's total assets are 8.1 billion KRW, representing 14.74% of the parent's consolidated assets.
The direct dilution impact on existing shareholders of the parent ROKIT HEALTHCARE is limited, but there is an indirect impact from the reduction in ownership percentage of the subsidiary.
[AI Summary]The subsidiary's Nasdaq listing is a positive factor for growth as it provides funding for expanding the long-term regeneration platform business. While the short-term dilution burden for parent shareholders is minimal, changes in equity value may occur depending on the size and terms of the listing.
KOSDAQ Filing Information
Decision on Listing of Stocks, etc. on Overseas Securities Market (Major Management Matters of Subsidiary)
Company: ROKIT HEALTHCARE (376900)
Submission: ROKIT HEALTHCARE Inc.
Under KRX KOSDAQ Market Division, Amended (Refer to related filing)